| Gene symbol | TNFSF13 | Synonyms | APRIL, CD256, TALL-2, TALL2, TNLG7B, TRDL-1, UNQ383/PRO715, ZTNF2 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17p13.1 | dbXrefs | |
| Description | TNF superfamily member 13 | ||||
| Gene symbol | TNFSF13B | Synonyms | BAFF, BLYS, CD257, DTL, TALL-1, TALL1, THANK, TNFSF20, TNLG7A, ZTNF4 | Type of gene | protein-coding |
| Chromosome | 13 | Map location | 13q33.3 | dbXrefs | |
| Description | TNF superfamily member 13b | ||||
| GTO ID | GTC3661 |
| Trial ID | NCT06132711 |
| Disease | Multiple Myeloma |
| Altered gene | TNFSF13|TNFSF13B |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | APRIL-BAFF-Bicephali CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Safety and Efficacy of APRIL-BAFF-Bicephali CAR-T in Relapsed, Refractory Multiple Myeloma-A Single-center, Open-label, Single-arm Clinical Study |
| Year | 2023 |
| Country | China |
| Company sponsor | Xuzhou Medical University |
| Other ID(s) | XYFY2023-KL144-01 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||